Speclipse, Inc., decided to increase the spectrum of their services by building a mobile application enable users age ranges 50 to 70 years old or anyone diagnosed with skin cancer or disease or users who has symptoms leads to the skin cancer for early diagnosis through Artificial Intelligence (AI) enable image recognition Technology.
On top of that, Speclipse wanted to have tele-clinic feature included in the application which allows patients and doctors interact online eliminating the requirement to visits clinics physically and get the feedback from the dermatologist instantly.